New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor.
Ishida T, Takahashi T, Nishida T, Ohnishi H, Tsuboyama T, Sato S, Nakahara Y, Miyazaki Y, Takeno A, Kurokawa Y, Saito T, Yamashita K, Tanaka K, Yamamoto K, Makino T, Yamasaki M, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y.
Ishida T, et al. Among authors: nakahara y.
Gastric Cancer. 2022 Jan;25(1):218-225. doi: 10.1007/s10120-021-01234-0. Epub 2021 Aug 20.
Gastric Cancer. 2022.
PMID: 34417657